Barbara Zdrazil is a group leader at the Department of Pharmaceutical Sciences, University of Vienna, Austria, and works as a safety data scientist for the European Bioinformatics Institute (EMBL-EBI), UK.
She received her PhD in Pharmaceutical Chemistry from the University of Vienna and performed her postdoctoral studies at the University of Düsseldorf, Germany. Barbara contributed to many EU-funded projects (eTOX, OpenPHACTS, EU-ToxRisk) and is leading a nationally funded FWF project focusing on hepatic OATPs since 2017. In 2019, Barbara accomplished her Venia Docendi in Pharmacoinformatics at the University of Vienna.
Barbara's research is concentrated on integrating Data Science approaches into the Computational Molecular Design process. She focuses on off-targets (mainly hepatic uptake transporters of the SLC family), and develops automatized computational techniques to link heterogeneous data sources, perform bioactivity profiling, and generate predictive models – especially for toxicity predictions. In addition, Barbara is interested in large-scale data analyses including time trend analyses by utilizing public domain data. At EMBL-EBI, Barbara is contributing to Open Targets, a project which aims to enable systematic target identification and prioritization.